85 related articles for article (PubMed ID: 8738067)
1. A paradox of thrombogenesis by streptokinase and its prevention by iloprost and camonagrel.
Korbut R; Gryglewski RJ
Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):167-74. PubMed ID: 8738067
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of thrombogenesis during pharmacological thrombolysis.
Korbut R; Gryglewski RJ
Pol J Pharmacol; 1996; 48(1):85-8. PubMed ID: 9112633
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic activity of beta-adrenolytic drug, sotalol.
Korbut R; Swies J; Marcinkiewicz E; Gryglewski RJ
J Physiol Pharmacol; 1998 Mar; 49(1):51-60. PubMed ID: 9594410
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of anti-thrombotic, thrombolytic and fibrinolytic actions of camonagrel--a new thromboxane synthase inhibitor.
Gryglewski RJ; Szczeklik A; Korbut R; Swies J; Musiał J; Krzanowski M; Maga P
Wien Klin Wochenschr; 1995; 107(9):283-9. PubMed ID: 7778318
[TBL] [Abstract][Full Text] [Related]
5. On the mechanism of thrombolytic action of thromboxane synthetase inhibitors.
Korbut R; Dembińska-Kieć A; Swies J; Zmuda A; Gryglewski RJ
Thromb Haemost; 1987 Oct; 58(3):827-30. PubMed ID: 3324381
[TBL] [Abstract][Full Text] [Related]
6. Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
Herbert JM; Bernat A; Sainte-Marie M; Dol F; Rinaldi M
Thromb Haemost; 1993 Mar; 69(3):268-71. PubMed ID: 8470050
[TBL] [Abstract][Full Text] [Related]
7. Effect of ticlopidine on streptokinase-induced thrombolysis in rats.
Gryglewski RJ; Korbut R; Swies J; Uracz W
Wien Klin Wochenschr; 1999 Feb; 111(3):98-102. PubMed ID: 10093891
[TBL] [Abstract][Full Text] [Related]
8. Vane's blood-bathed organ technique adapted to examine the endothelial effects of cardiovascular drugs in vivo.
Gryglewski RJ; Mackiewicz Z
Pharmacol Rep; 2010; 62(3):462-7. PubMed ID: 20631409
[TBL] [Abstract][Full Text] [Related]
9. Effect of aspirin and iloprost on adhesion of platelets to intact endothelium in vivo.
Shanberge JN; Kajiwara Y; Quattrociocchi-Longe T
J Lab Clin Med; 1995 Jan; 125(1):96-101. PubMed ID: 7529817
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin as a major endogenous regulator of endothelial function.
Gryglewski RJ; Uracz W; Chłopicki S; Marcinkiewicz E
Pediatr Pathol Mol Med; 2002; 21(3):279-90. PubMed ID: 12056503
[TBL] [Abstract][Full Text] [Related]
11. Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model.
Perkins WR; Vaughan DE; Plavin SR; Daley WL; Rauch J; Lee L; Janoff AS
Thromb Haemost; 1997 Jun; 77(6):1174-8. PubMed ID: 9241753
[TBL] [Abstract][Full Text] [Related]
12. Prostacyclin and the mechanism of action of defibrotide.
Gryglewski RJ; Marcinkiewicz E; Radomski M; Swies J
Eicosanoids; 1989; 2(3):163-7. PubMed ID: 2517030
[TBL] [Abstract][Full Text] [Related]
13. Kinins and thrombolysis.
Swies J; Chłopicki S; Gryglewski RJ
J Physiol Pharmacol; 1993 Jun; 44(2):171-7. PubMed ID: 8358053
[TBL] [Abstract][Full Text] [Related]
14. Prevention of thrombosis and enhancement of thrombolysis in rabbits by SR 121787, a glycoprotein II/III antagonist.
Hoffmann P; Bernat A; Savi P; Herbert JM
J Pharmacol Exp Ther; 1998 Aug; 286(2):670-5. PubMed ID: 9694919
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis by thienopyridines and their congeners.
Gryglewski RJ; Dupin JP; Uracz W; Swiês J; Madej J; Hou G; Gravier D; Casadebaig F
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):683-93. PubMed ID: 11192941
[TBL] [Abstract][Full Text] [Related]
16. Pneumotoxicity of lipopolysaccharide in nitric oxide-deficient rats is limited by a thromboxane synthase inhibitor.
Wołkow PP; Bartuś JB; Gryglewski RJ
J Physiol Pharmacol; 1997 Dec; 48(4):645-53. PubMed ID: 9444613
[TBL] [Abstract][Full Text] [Related]
17. In vitro analysis of synergistic effects of fibrinolytic agents and prostacyclin analogues.
Spiecker M; Heinke B; Meyer J; Darius H
Haemostasis; 1997; 27(4):184-92. PubMed ID: 9483173
[TBL] [Abstract][Full Text] [Related]
18. Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost.
Antoniou T; Kapetanakis EI; Theodoraki K; Rellia P; Thanopoulos A; Kotiou M; Zarkalis D; Alivizatos P
Heart Surg Forum; 2002; 5(4):354-7. PubMed ID: 12538117
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide, prostacyclin (PGI2) and tissue plasminogen activator (t-PA): alliance or neutrality?
Gryglewski RJ
Pol J Pharmacol; 1995; 47(5):467-72. PubMed ID: 8868142
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
